Formulari Ubat KKM (FUKKM)

# Generic Name MDC Category Indications Dosage
1441 Sodium Chloride 0.18% with Dextrose 10% Injection B05XA03904P6001XX B For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions According to the needs of the patient
1442 Sodium Chloride 0.18% with Dextrose 4.23% Injection B05XA03904P6004XX B For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions According to the needs of the patient
1443 Sodium Chloride 0.45% Injection B05XA03100P6001XX B For replenishing fluid and for restoring / maintaining the concentration of sodium and chloride ions 100 - 1000 ml by IV or according to the needs of the patient
1444 Sodium Chloride 0.45% with Dextrose 10% Injection B05XA03904P6002XX B For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions According to the needs of the patient
1445 Sodium Chloride 0.45% with Dextrose 5% Injection B05XA03904P6005XX B For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions According to the needs of the patient
1446 Sodium Chloride 0.9% Eye Drops S01XA03000D2001XX C Irrigation of conjunctival sac 1 - 2 drops every 3 - 4 hours
1447 Sodium Chloride 0.9% Injection B05XA03100P6002XX C+ For replenishing fluid and for restoring/maintaining the concentration of sodium and chloride ions 100 - 1000 ml by IV or according to the needs of the patient
1448 Sodium Chloride 0.9% with Dextrose 5% Injection B05XA03904P6003XX C+ For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions According to the needs of the patient
1449 Sodium Chloride 20% Injection B05XA03100P9902XX B Addition of sodium electrolyte in parenteral nutrition bags especially in paediatrics or neonates with restricted fluid allowance According to the needs of the patient
1450 Sodium Chloride 3% Injection B05XA03100P9901XX B Acute dilutional hyponatraemia According to the needs of the patient
1451 Sodium Chromate (Chromium-51) Solution V09GX00143L9901XX A* Labelling of erythrocytes for the investigation of haemotological disorders Usual dose range : 10 - 200 microcuries IV by IV injection
1452 Sodium Citrate 0.3 M Solution B05CB02136L9901XX B Prophylaxis for aspiration pneumonitis (use as an oral solution) Dose depending on clinical cases. Usually, 30 ml given 10- 60 minutes before anaesthesia prior to elective cesarean surgery is an effective antacid
1453 Sodium Citrate 3.8% Solution B05CB02136H3001XX B Sterile solution for irrigation or washout of infected bladder Dose depending on clinical cases
1454 Sodium Citrate, Citric Acid Mixture 3 g/10 ml B05CB02136L2101XX B Citrates and citric acid solutions are used to correct the acidosis of certain renal tubular disorders to treat metabolic acidosis for long-term urine alkalinization for prevention and treatment of uric acid and calcium kidney stones and as nonparticulate neutralizing buffers ADULT 10 - 20 ml. CHILD up to 1 year 2.5 ml tds; 1-5 year 5 ml tds; 6-12 years 10 ml tds. To be taken well diluted with water
1455 Sodium Cromoglycate 2% Eye Drops S01GX01520D2001XX A/KK Prevention and treatment of allergic conjunctivitis including seasonal and perennial allergic conjunctivitis and vernal keratoconjunctivitis 1 or 2 drops 4 times daily
1456 Sodium Dichloroisocyanurate 2.5 g Tablet V07AV00000T1001XX C Low and medium level disinfectant 50 - 10,000 ppm av chlorine
1457 Sodium Dichloroisocyanurate 5 g Tablet V07AV00000T1002XX C Low and medium level disinfectant 50 - 10,000 ppm av chlorine
1458 Sodium Fusidate 2% Ointment D06AX01520G5001XX A Skin infections caused by staphylococci, streptococci, corynebacterium minutissumun and other sodium fusidate-sensitive organisms Apply to affected area 2 - 3 times daily
1459 Sodium glycerophosphate for addition into infusion solution, 20ml vial B05XA14171P3001XX A Indicated in adult patients and infants as a supplement in intravenous nutrition to meet the requirement of phosphate. Adults: The recommended dosage is individual. The recommended daily dosage of phosphate during intravenous nutrition would normally be 10-20mmol. This can be met by using 10-20ml of sodium glycerophosphate to the infusion solution or to the admixture for which compatibility has been proved. Infants: The recommended dosage is individual. The recommended dose for infants and neonates is 1.0-1.5 mmol/kg bodyweight/day.
1460 Sodium Hypochlorite Solution V07AV00000L9903XX C Low-level disinfectant and antiseptic Antiseptic: less than 0.5%. Disinfectant: 5%
1461 Sodium Iodide (Iodide-131) Injection V09FX03200P3001XX A* Used in the determination of various thyroid functions 5 - 50 millicuries
1462 Sodium Iodide (Iodine-131) Capsule V09FX03200C1001XX A* Determination of various thyroid functions 5 - 10 milicuries (5 mCi for whole body scan)
1463 Sodium Iodide (Iodine-131) Capsule (Therapeutic) V10XA01200C1001XX A* i) Thyrotoxicosis ii) Thyroid carcinoma i) 2 - 30 millicuries ii) 80 - 300 millicuries
1464 Sodium Iodide (Iodine-131) Solution V10XA01200L9901XX A* i) Thyrotoxicosis ii) Thyroid carcinoma i) 5-25 millicuries ii) 30-150 millicuries
1465 Sodium Nitrite 30 mg/ml Injection V03AB08220P3001XX B For cyanide poisoning Adult: 300 mg sodium nitrite IV over 3 minutes followed after 5 minutes with 12.5g sodium thiosulphate IV administered over 10 minutes. CHILD: 4 - 10 mg/kg of sodium nitrite (max: 300 mg) followed by 400 mg/kg of sodium thiosulfate, as a 25 or 50% solution (max: 12.5 g). Methaemoglobin concentration should not exceed 30-40%. If symptoms of cyanide toxicity recur, the doses of nitrite and thiosulfate may be repeated after 30 min at half the initial doses.
1466 Sodium Nitroprusside 10 mg/ml Injection C02DD01520P3001XX A i) Hypertensive crisis ii) Controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures i) By IV infusion, initially 0.5-1.5 mcg/kg/min, then adjusted before increasement of 0.5 mcg/kg/min every 5 mins within range 0.5-8 mcg/kg/min (lower doses in patients already receiving other antihypertensives); stop if marked response not obtained with max dose in 10 minutes. Use only in infusion with 5 % Dextrose IV. ii) By IV infusion, max: 1.5 mcg/kg/min
1467 Sodium Phosphate (Phosphorus-32) Injection V10XX01162P3001XX A* Polycythemia vera, chronic myeloid and chronic lymphocytic leukaemia and palliative treatment of bone metastases Initially 5 millicuries, follow if necessary by a dose of not more than 3 or 4 millicurie at intervals of not less than 2 months
1468 Sodium picosulfate, magnesium oxide & citric acid powder for oral solution A06AB58-921-L50-01-XXX A/KK  To clean the bowel prior to X-ray examination or endoscopy.  To clean the bowel prior to surgery when judged clinically necessary. ADULTS: i) Split-Dose Dosing Regimen (Preferred Method) • First dose should be taken during the evening before the procedure (e.g. 5:00 to 9:00 PM) followed by five 250 ml drinks (upper line on the dosing cup) of clear liquids before bed. Clear liquids should be consumed within 5 hours. • Second dose to be taken the next day approximately 5 hours before the procedure followed by at least three 250ml drinks of clear liquids before the procedure. Clear liquids should be consumed within 5 hours up until 2 hour before the time of the procedure. ii) Day-Before Dosing Regimen (Alternative Method) (Alternative dosing method for patients for whom the Split-Dosing is inappropriate). • First dose to be taken in the afternoon or early evening (e.g., 4:00 to 6:00 PM) before the procedure followed by five 250 ml drinks (upper line on the dosing cup) of clear liquids before the next dose. Clear liquids should be consumed within 5 hours. • Second dose to be taken approximately 6 hours later in the late evening (e.g., 10:00 PM to 12:00 AM), the night before the procedure followed by three 250 ml drinks of clear liquids before bed. Clear liquids should be consumed within 5 hours. CHILDREN: The first dose reconstituted in water as directed, taken before 8 am on the day before the procedure. Second dose 6 to 8 hours later.  1 - 2 years: 1⁄4 sachet morning, 1⁄4 sachet afternoon  2 - 4 years: 1⁄2 sachet morning, 1⁄2 sachet afternoon  4 - 9 years: 1 sachet morning, 1⁄2 sachet afternoon  9 and above: adult dose
1469 Sodium Polystyrene Sulphonate Powder V03AE01520F2101XX A Treatment and prevention of hyperkalaemia associated with anuria or severe oliguria, in dialysis patients or those on prolonged peritoneal dialysis ADULT : Oral : 15 g 1 - 4 times/day. Rectal : 30 g in 100 ml 2% methylcellulose and 100 ml water as a daily retention enema. Retain for 9 hours followed by non-sodium cleansing enema. CHILD : 1 g/kg in 1 - 4 doses in acute hyperkalemia. Maintenance : 0.5 g/kg/daily
1470 Sodium Tetradecyl Sulphate 1 % Injection C05BB04183P3001XX A* Sclerotherapy of oesophageal varices, haemorrhoids and varicose veins 0.5-2 mL into the submucosal layer at the base of the oesophageal varix or the haemorrhoid; several injections may be given at different sites, max. total injected 10-15 mL of 1% per treatment

Halaman-halaman